Givaudan posts solid H1 growth despite currency headwinds and litigation costs

Givaudan, the Swiss flavor and fragrance giant, reported solid top-line growth in the first half of 2026 even as currency headwinds and litigation costs squeezed its bottom line. The company posted sales of 3.8 billion Swiss francs, up 3.6 percent on a like-for-like basis—a measure that strips out currency swings and acquisitions to show underlying business momentum. When reported in Swiss francs, however, the headline number fell 1.7 percent, a reminder of how the franc's strength against other currencies has become a persistent drag on results.

The fragrance and beauty division, Givaudan's larger business, delivered the stronger performance with 6.5 percent like-for-like growth. Within that segment, fine fragrance climbed 7.3 percent and consumer products jumped 9.2 percent, though fragrance ingredients and active beauty declined 4.1 percent. The taste and wellbeing division, by contrast, barely moved, growing just 0.5 percent on a like-for-like basis. Regional performance was mixed: Asia Pacific accelerated to 4.9 percent growth, but North America and Latin America both contracted, each falling 1.5 percent.

Profitability tells a different story. Adjusted EBITDA—earnings before interest, taxes, depreciation and amortization—reached 923 million francs, but the margin compressed to 24.3 percent from 25.2 percent a year earlier. The company absorbed 103 million francs in non-recurring costs during the period, primarily from litigation settlements and provisions tied to competition authority investigations into the fragrance industry. An additional 83 million francs in litigation costs hit the fragrance and beauty division specifically, while the taste and wellbeing unit recorded a 53 million franc provision related to an adverse judgment in Missouri over alleged pulmonary injuries linked to diacetyl and 2,3 pentanedione in flavoring compounds. Restructuring expenses and competition investigation costs added another 20 million francs to the burden.

CEO Christian Stammkoetter framed the results as evidence of resilience. "Despite ongoing geopolitical and macroeconomic challenges, our business continued to display good growth momentum and industry leading profitability," he said in a statement. The company is managing higher input costs by working with customers on price increases, a delicate negotiation in an inflationary environment where demand remains fragile in some regions.

Cash generation weakened considerably. Operating cash flow fell to 184 million francs from 248 million a year earlier. Adjusted free cash flow—the cash available after capital investments—turned negative at 119 million francs, or minus 3.1 percent of sales, compared to a small negative 16 million francs in the prior year period. The deterioration reflected both higher capital spending, which jumped to 5.4 percent of sales from 4.4 percent, and temporary working capital effects as inventory and receivables swelled. Net debt climbed to 4.6 billion francs from 3.7 billion at year-end 2025, pushing the net debt-to-EBITDA ratio to 2.8 from 2.1.

Net income fell to 475 million francs from 592 million, a decline of nearly 20 percent, with the net profit margin contracting to 12.5 percent from 15.3 percent. Adjusted earnings per share dropped to 60.25 francs from 66.71 francs.

Looking ahead, Givaudan is targeting 4 to 6 percent average like-for-like sales growth through 2030 under its "Driving sustainable growth with customers" strategy. The company plans to expand into adjacent high-value markets while maintaining its core business, and it aims to generate more than 12 percent average adjusted free cash flow over the five-year period. It is also pursuing sustainability goals aligned with science-based targets, including net-zero emissions and responsible sourcing by 2030. The near-term challenge, however, is clear: converting growth into cash while managing litigation exposure and navigating an uncertain macroeconomic backdrop.